fda glp-1 safety warning september 2025 GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists FDA issued a warning letter

The clinical effectiveness may be comparable when produced by a reputable pharmacy, but it is not identical to the brand-name product

Oxidative stress and free radical accumulation may lead to sustained immunocyte challenge and result in depletion of intracellular glutathione

Users who expect dramatic results in one or two weeks from concentration increases will be disappointed, and may unnecessarily escalate further based on inaccurate assessment

In this review, we aim to summarize our current understanding of eryptosis, formulate a nomenclature and guidelines to interpret results of eryptosis studies, provide a synopsis of morphological and biochemical features of eryptosis, and highlight the role of eryptosis in health and disease, including its druggability